Zevra Therapeutics (ZVRA) announced, on Rare Disease Day, the launch of a new disease state awareness campaign, ‘Learn NPC, Read Between the ...
Zevra used the awareness day to roll out the “Learn NPC, Read Between the Signs” disease awareness campaign. The biotech won ...
The brain drug developer is continuing a trial despite a recommendation it be stopped for futility. Elsewhere, Eli Lilly ...
GlobalData on MSN21h
Zevra sells priority review voucher for $150m to support drug launchesZevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party. The ...
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...
ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...
Jones brings a broad background beyond the pharma space, having led or worked in HR at Sangamo Therapeutics and Novartis Diagnostics, as well as LendingClub and Gap, Inc. More from the Boards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback